Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000044

CEO bought 62,000 shares at an average $0.01 ($698)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-25 Purchase : show line 1 in the form +15,000 $0.01 $177 24,873,797 D
2019-07-25 Purchase : show line 2 in the form +10,000 $0.01 $118 24,883,797 D
2019-07-26 Purchase : show line 3 in the form +12,000 $0.01 $139 24,895,797 D
2019-07-31 Purchase : show line 4 in the form +2,000 $0.01 $23 24,897,797 D
2019-08-07 Purchase : show line 5 in the form +15,000 $0.01 $159 24,912,797 D
2019-08-07 Purchase : show line 6 in the form +2,000 $0.01 $21 24,914,797 D
2019-08-07 Purchase : show line 7 in the form +2,000 $0.01 $20 24,916,797 D
2019-08-07 Purchase : show line 8 in the form +2,000 $0.01 $20 24,918,797 D
2019-08-07 Purchase : show line 9 in the form +2,000 $0.01 $20 24,920,797 D
Open-market purchases · 62,000 sh · avg $0.01 · $698
Loading xslF345X03/primary_doc.xml…